These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 35430131)

  • 21. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
    Panidis D; Farmakiotis D; Rousso D; Kourtis A; Katsikis I; Krassas G
    Fertil Steril; 2008 Apr; 89(4):899-906. PubMed ID: 17980364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The gut microbial composition in polycystic ovary syndrome with insulin resistance: findings from a normal-weight population.
    He F; Li Y
    J Ovarian Res; 2021 Mar; 14(1):50. PubMed ID: 33773586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered cortisol metabolism in polycystic ovary syndrome: insulin enhances 5alpha-reduction but not the elevated adrenal steroid production rates.
    Tsilchorozidou T; Honour JW; Conway GS
    J Clin Endocrinol Metab; 2003 Dec; 88(12):5907-13. PubMed ID: 14671189
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Obesity and the polycystic ovary syndrome.
    Gambineri A; Pelusi C; Vicennati V; Pagotto U; Pasquali R
    Int J Obes Relat Metab Disord; 2002 Jul; 26(7):883-96. PubMed ID: 12080440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Obesity and Insulin Resistance, Not Polycystic Ovary Syndrome, Are Independent Predictors of Bone Mineral Density in Adolescents and Young Women.
    Pereira-Eshraghi CF; Chiuzan C; Zhang Y; Tao RH; McCann M; Neugut YD; Printz A; Fennoy I; Cree-Green M; Oberfield SE; Sopher AB
    Horm Res Paediatr; 2019; 92(6):365-371. PubMed ID: 32348991
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determinants of low bone mineral density in premenopausal polycystic ovary syndrome patients.
    Karadağ C; Yoldemir T; Gogas Yavuz D
    Gynecol Endocrinol; 2017 Mar; 33(3):234-237. PubMed ID: 27908213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessing C reactive protein/albumin ratio as a new biomarker for polycystic ovary syndrome: a case-control study of women from Bahraini medical clinics.
    Kalyan S; Goshtesabi A; Sarray S; Joannou A; Almawi WY
    BMJ Open; 2018 Oct; 8(10):e021860. PubMed ID: 30368447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
    Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
    Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Genetic aspects of polycystic ovary syndrome].
    Jakubowski L
    Endokrynol Pol; 2005; 56(3):285-93. PubMed ID: 16350721
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Study of carbohydrate metabolism indices and adipocytokine profile and their relationship with androgens in polycystic ovary syndrome after menopause.
    Markopoulos MC; Valsamakis G; Kouskouni E; Boutsiadis A; Papassotiriou I; Creatsas G; Mastorakos G
    Eur J Endocrinol; 2013 Jan; 168(1):83-90. PubMed ID: 23076844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma ghrelin, obesity, and the polycystic ovary syndrome: correlation with insulin resistance and androgen levels.
    Pagotto U; Gambineri A; Vicennati V; Heiman ML; Tschöp M; Pasquali R
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5625-9. PubMed ID: 12466363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone mineral density in women with polycystic ovary syndrome.
    Katulski K; Slawek S; Czyzyk A; Podfigurna-Stopa A; Paczkowska K; Ignaszak N; Podkowa N; Meczekalski B
    J Endocrinol Invest; 2014 Dec; 37(12):1219-24. PubMed ID: 25245338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Body composition, bone mineral density and fractures in late postmenopausal women with polycystic ovary syndrome - a long-term follow-up study.
    Schmidt J; Dahlgren E; Brännström M; Landin-Wilhelmsen K
    Clin Endocrinol (Oxf); 2012 Aug; 77(2):207-14. PubMed ID: 22385110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inflammatory Markers in Women with Polycystic Ovary Syndrome.
    Rudnicka E; Kunicki M; Suchta K; Machura P; Grymowicz M; Smolarczyk R
    Biomed Res Int; 2020; 2020():4092470. PubMed ID: 32219132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Review of the effects of polycystic ovary syndrome on Cognition: Looking beyond the androgen hypothesis.
    Perović M; Wugalter K; Einstein G
    Front Neuroendocrinol; 2022 Oct; 67():101038. PubMed ID: 36154816
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vitamin D and Polycystic Ovary Syndrome: a Narrative Review.
    Mu Y; Cheng D; Yin TL; Yang J
    Reprod Sci; 2021 Aug; 28(8):2110-2117. PubMed ID: 33113105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inflammation in Polycystic Ovary Syndrome: underpinning of insulin resistance and ovarian dysfunction.
    González F
    Steroids; 2012 Mar; 77(4):300-5. PubMed ID: 22178787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Androgen-induced gut dysbiosis disrupts glucolipid metabolism and endocrinal functions in polycystic ovary syndrome.
    Han Q; Wang J; Li W; Chen ZJ; Du Y
    Microbiome; 2021 May; 9(1):101. PubMed ID: 33957990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Role of Glp-1 Receptor Agonists in Insulin Resistance with Concomitant Obesity Treatment in Polycystic Ovary Syndrome.
    Bednarz K; Kowalczyk K; Cwynar M; Czapla D; Czarkowski W; Kmita D; Nowak A; Madej P
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Rat Model of Maternal Polycystic Ovary Syndrome Shows that Exposure to Androgens In Utero Results in Dysbiosis of the Intestinal Microbiota and Metabolic Disorders of the Newborn Rat.
    Gulan T; Yeernuer T; Sui S; Mayinuer N
    Med Sci Monit; 2019 Dec; 25():9377-9391. PubMed ID: 31815927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.